Date Filed | Type | Description |
10/03/2023 |
4
| Fairmount Funds Management LLC (10% Owner) has filed a Form 4 on Dianthus Therapeutics, Inc. /DE/
Txns:
| Bought 24,670 shares
@ $13.63, valued at
$336.3k
|
|
09/28/2023 |
4
| Fairmount Funds Management LLC (10% Owner) has filed a Form 4 on Dianthus Therapeutics, Inc. /DE/
Txns:
| Bought 30,000 shares
@ $13.15, valued at
$394.5k
|
|
02/09/2023 |
4
| Third Rock Ventures IV, L.P. (10% Owner) has filed a Form 4 on Magenta Therapeutics, Inc.
Txns:
| Sold 2,200,000 shares
@ $0.83, valued at
$1.8M
Sold 1,500,000 shares
@ $0.82, valued at
$1.2M
|
|
12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/17/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
08/01/2022 |
4
| Olson Lisa (See Remarks) has filed a Form 4 on Magenta Therapeutics, Inc.
Txns:
| Granted 100,000 options to buy
@ $1.57, valued at
$157k
|
|
08/01/2022 |
4
| Beetham Thomas W. (See Remarks) has filed a Form 4 on Magenta Therapeutics, Inc.
Txns:
| Granted 75,000 options to buy
@ $1.57, valued at
$117.8k
|
|
08/01/2022 |
4
| Humphrey Jeffrey (Chief Medical Officer) has filed a Form 4 on Magenta Therapeutics, Inc.
Txns:
| Granted 75,000 options to buy
@ $1.57, valued at
$117.8k
|
|
08/01/2022 |
4
| GARDNER JASON (See Remarks) has filed a Form 4 on Magenta Therapeutics, Inc.
Txns:
| Granted 187,500 options to buy
@ $1.57, valued at
$294.4k
|
|
08/01/2022 |
4
| Nichols David Wayne (Chief Technical Officer) has filed a Form 4 on Magenta Therapeutics, Inc.
Txns:
| Granted 75,000 options to buy
@ $1.57, valued at
$117.8k
|
|
08/01/2022 |
4
| Mahoney Stephen F. (See Remarks) has filed a Form 4 on Magenta Therapeutics, Inc.
Txns:
| Granted 130,000 options to buy
@ $1.57, valued at
$204.1k
|
|
08/01/2022 |
4
| Stants Kristen (Chief People Officer) has filed a Form 4 on Magenta Therapeutics, Inc.
Txns:
| Granted 85,000 options to buy
@ $1.57, valued at
$133.5k
|
|
08/01/2022 |
4
| Deardorf Caren (Chief Commercial Officer) has filed a Form 4 on Magenta Therapeutics, Inc.
Txns:
| Granted 75,000 options to buy
@ $1.57, valued at
$117.8k
|
|
06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/30/2022 |
4
| Scadden David (Director) has filed a Form 4 on Magenta Therapeutics, Inc.
Txns:
| Granted 20,000 options to buy
@ $1.21, valued at
$24.2k
|
|
06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/06/2022 |
4
| GARDNER JASON (See Remarks) has filed a Form 4 on Magenta Therapeutics, Inc.
Txns:
| Granted 3,000 shares
@ $0.99, valued at
$3k
|
|
06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/19/2022 |
4
| Olson Lisa (See Remarks) has filed a Form 4 on Magenta Therapeutics, Inc.
Txns:
| Granted 50,000 options to buy
@ $1.18, valued at
$59k
|
|
05/19/2022 |
4
| Humphrey Jeffrey (Chief Medical Officer) has filed a Form 4 on Magenta Therapeutics, Inc.
Txns:
| Granted 50,000 options to buy
@ $1.18, valued at
$59k
|
|
05/19/2022 |
4
| GARDNER JASON (See Remarks) has filed a Form 4 on Magenta Therapeutics, Inc.
Txns:
| Granted 162,500 options to buy
@ $1.18, valued at
$191.8k
|
|
05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|